Regeneron Pharmaceuticals, Inc(NASDAQ:REGN) 
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovas...
Website: http://www.regeneron.com
Founded: 1988
Full Time Employees: 8,314
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 610.65
H 612.99
L 572.00
C 573.45
V 1,547,958
10EMA 573.45
20EMA 573.45
60EMA 573.45
120EMA 573.45
250EMA 573.45